We found that the blockade of IL-10 markedly attenuated the inhibitory effect of MS, as shown by exacerbated colon inflammation, exaggerated weight loss, higher DAI and elevated amount of IL-6 (Fig. 6E). This evidence concerns the gene IL6 and myeloid sarcoma.